These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2182793)

  • 1. Enhanced expression of the sis and c-myc oncogenes in human meningiomas.
    Kazumoto K; Tamura M; Hoshino H; Yuasa Y
    J Neurosurg; 1990 May; 72(5):786-91. PubMed ID: 2182793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of disregulated c-myc but not c-sis/PDGF in atypical and anaplastic meningiomas.
    Nagashima G; Aoyagi M; Yamamoto S; Wakimoto H; Tamaki M; Yamamoto K; Fujimoto T; Hirakawa K
    Clin Neurol Neurosurg; 2001 Apr; 103(1):13-8. PubMed ID: 11311470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and expression of the c-sis gene and its relationship to sporadic meningiomas.
    Smidt M; Dumanski JP; Collins VP; Ratner L
    Cancer Res; 1991 Aug; 51(16):4295-8. PubMed ID: 1868450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of proto-oncogene expression and proliferation and meningiomas.
    Detta A; Kenny BG; Smith C; Logan A; Hitchcock E
    Neurosurgery; 1993 Dec; 33(6):1065-74. PubMed ID: 8133992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of the c-myc protooncogene in human intracranial meningiomas.
    Kim JH; Lee SH; Cho KJ; Jang JJ; Hong SI; Lee JH
    J Korean Med Sci; 1993 Feb; 8(1):68-72. PubMed ID: 8343222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of c-sis and c-fos genes in human meningiomas and neurinomas.
    Riva P; Larizza L
    Int J Cancer; 1992 Jul; 51(6):873-7. PubMed ID: 1353485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes.
    Burgart LJ; Robinson RA; Haddad SF; Moore SA
    Mod Pathol; 1991 Mar; 4(2):183-6. PubMed ID: 1675468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of Alu sequences in the fifth c-sis intron in individuals with meningiomas.
    Smidt M; Kirsch I; Ratner L
    J Clin Invest; 1990 Oct; 86(4):1151-7. PubMed ID: 2212004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products.
    Maxwell M; Galanopoulos T; Hedley-Whyte ET; Black PM; Antoniades HN
    Int J Cancer; 1990 Jul; 46(1):16-21. PubMed ID: 2163990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of c-sis and other cellular proto-oncogenes in human sarcoma cell lines and biopsies.
    Fahrer C; Brachmann R; von der Helm K
    Int J Cancer; 1989 Oct; 44(4):652-7. PubMed ID: 2793239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic alterations in sarcomas: a histologic correlative study with use of oncogene panels.
    Maillet MW; Robinson RA; Burgart LJ
    Mod Pathol; 1992 Jul; 5(4):410-4. PubMed ID: 1495946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.
    Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P
    Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogene amplification in pediatric brain tumors.
    Wasson JC; Saylors RL; Zeltzer P; Friedman HS; Bigner SH; Burger PC; Bigner DD; Look AT; Douglass EC; Brodeur GM
    Cancer Res; 1990 May; 50(10):2987-90. PubMed ID: 2334901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative study of c-sis and c-myc and cellular phenotypes in the arterial media and atherosclerotic plaques].
    Yang HP
    Zhonghua Bing Li Xue Za Zhi; 1992 Dec; 21(6):349-51. PubMed ID: 1299526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of c-sis (PDGF B-chain) and PDGF A-chain genes in ten human malignant mesothelioma cell lines derived from primary and metastatic tumors.
    Versnel MA; Hagemeijer A; Bouts MJ; van der Kwast TH; Hoogsteden HC
    Oncogene; 1988 Jun; 2(6):601-5. PubMed ID: 3290807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transducible TAT-RIZ1-PR protein exerts histone methyltransferase activity and tumor-suppressive functions in human malignant meningiomas.
    Ding MH; Wang Z; Jiang L; Fu HL; Gao J; Lin XB; Zhang CL; Liu ZY; Shi YF; Qiu GZ; Ma Y; Cui DX; Hu GH; Jin WL
    Biomaterials; 2015 Jul; 56():165-78. PubMed ID: 25934289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low level amplification of c-sis and c-myc in a spontaneous osteosarcoma model.
    Kochevar DT; Kochevar J; Garrett L
    Cancer Lett; 1990 Sep; 53(2-3):213-22. PubMed ID: 2208081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated c-myc messenger RNA in multiple myeloma cell lines.
    Fourney R; Palmer M; Ng A; Dietrich K; Belch A; Paterson M; Brox L
    Dis Markers; 1990; 8(3):117-24. PubMed ID: 1980237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.